Jupiter Neurosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JUNS and other ETFs, options, and stocks.

About JUNS

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. 

CEO
Christer Rosén
CEOChrister Rosén
Employees
4
Employees4
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
2015
Founded2015
Employees
4
Employees4

JUNS Key Statistics

Market cap
19.53M
Market cap19.53M
Price-Earnings ratio
-2.46
Price-Earnings ratio-2.46
Dividend yield
Dividend yield
Average volume
92.15K
Average volume92.15K
High today
$0.5998
High today$0.5998
Low today
$0.54
Low today$0.54
Open price
$0.5598
Open price$0.5598
Volume
58.35K
Volume58.35K
52 Week high
$3.33
52 Week high$3.33
52 Week low
$0.48
52 Week low$0.48

Stock Snapshot

The current Jupiter Neurosciences(JUNS) stock price is $0.56, with a market capitalization of 19.53M. The stock trades at a price-to-earnings (P/E) ratio of -2.46.

During the trading session on 2026-02-18, Jupiter Neurosciences(JUNS) shares reached a daily high of $0.60 and a low of $0.54. At a current price of $0.56, the stock is +3.5% higher than the low and still -6.8% under the high.

Trading activity shows a volume of 58.35K, compared to an average daily volume of 92.15K.

The stock's 52-week range extends from a low of $0.48 to a high of $3.33.

The stock's 52-week range extends from a low of $0.48 to a high of $3.33.

People also own

Based on the portfolios of people who own JUNS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.